Citation Impact
Citing Papers
Development without germ cells: The role of the germ line in zebrafish sex differentiation
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Myasthenia Gravis
2016 Standout
Animal models of human disease: zebrafish swim into view
2007 Standout
Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization success and demasculinizes males
2005
Spermatogenesis in fish
2009 Standout
Short-term exposure to the environmentally relevant estrogenic mycotoxin zearalenone impairs reproduction in fish
2010
Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009
2018 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Regulatory assessment of chemical mixtures: Requirements, current approaches and future perspectives
2016 Standout
In vivo toxicity studies of fusarium mycotoxins in the last decade: A review
2015 Standout
Effects of Endocrine Disrupters on Sexual, Gonadal Development in Fish
2009
Development of quantitative vitellogenin-ELISAs for fish test species used in endocrine disruptor screening
2004
Myasthenia gravis
2019 Standout
Effects of 17α-ethynylestradiol on EROD activity, spiggin and vitellogenin in three-spined stickleback (Gasterosteus aculeatus)
2007
The behaviour and ecology of the zebrafish,Danio rerio
2007 Standout
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
2005 Standout
Ecotoxicology of human pharmaceuticals
2005 Standout
Interpretation of fish biomarker data for identification, classification, risk assessment and testing of endocrine disrupting chemicals
2016
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research—Advantages and Current Limitations
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Long-Term Exposure to Environmental Concentrations of the Pharmaceutical Ethynylestradiol Causes Reproductive Failure in Fish
2004
Risk of non‐melanoma skin cancer in myasthenia patients treated with azathioprine
2013
The pros and cons of ecological risk assessment based on data from different levels of biological organization
2016 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Collapse of a fish population after exposure to a synthetic estrogen
2007 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Interspecies differences in biochemical, histopathological, and population responses in four wild fish species exposed to ethynylestradiol added to a whole lakeThis paper is part of the series “Forty Years of Aquatic Research at the Experimental Lakes Area”.
2009
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Myasthenia and risk of cancer: a population‐based case–control study
2014
Marine Strategy Framework Directive Task Group 8 Report: Contaminants and pollution effects
2010
Risk factors for childhood and adult primary brain tumors
2019
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Environmental influences in cancer aetiology
2005
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
An environmentally relevant concentration of estrogen induces arrest of male gonad development in zebrafish, Danio rerio
2005
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
2008
Screening and Testing for Endocrine Disruption in Fish—Biomarkers As “Signposts,” Not “Traffic Lights,” in Risk Assessment
2006
Rapid growth and out-crossing promote female development in zebrafish (Danio rerio)
2007
Use of azathioprine for non‐thymoma myasthenia and risk of cancer: a nationwide case–control study in D enmark
2013
Works of Lene Andersen being referenced
Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis
2008
Use of statins and risk of glioma: a nationwide case–control study in Denmark
2013
Effects of exposure to 17α-ethinylestradiol during early development on sexual differentiation and induction of vitellogenin in zebrafish (Danio rerio)
2003
Short-term exposure to low concentrations of the synthetic androgen methyltestosterone affects vitellogenin and steroid levels in adult male zebrafish (Danio rerio)
2005
Development of an ELISA for vitellogenin in whole body homogenate of zebrafish (Danio rerio)
2001
Zebrafish Danio rerio and roach Rutilus rutilus: Two species suitable for evaluating effects of endocrine disrupting chemicals?
2001
Evaluation of a 40 day Assay for Testing Endocrine Disrupters: Effects of an Anti-Estrogen and an Aromatase Inhibitor on Sex Ratio and Vitellogenin Concentrations in Juvenile Zebrafish (Danio rerio)
2004
Impaired larval development in broods of eelpout (Zoarces viviparus) in Danish coastal waters
2004